scholarly article | Q13442814 |
P50 | author | Christos Pantelis | Q5113577 |
Stephen J Wood | Q42733695 | ||
Murat Yücel | Q43643566 | ||
R Mark Wellard | Q46775018 | ||
Ben J Harrison | Q61606659 | ||
Dennis Velakoulis | Q87038602 | ||
Kerrie Clarke | Q114427365 | ||
P2093 | author name string | Alex Fornito | |
P433 | issue | 1-3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | schizophrenia | Q41112 |
P304 | page(s) | 328-331 | |
P577 | publication date | 2007-06-18 | |
P1433 | published in | Schizophrenia Research | Q7431607 |
P1476 | title | Evidence for neuronal dysfunction in the anterior cingulate of patients with schizophrenia: a proton magnetic resonance spectroscopy study at 3 T. | |
P478 | volume | 94 |
Q49551461 | 7T Proton Magnetic Resonance Spectroscopy of the Anterior Cingulate Cortex in First-Episode Schizophrenia. |
Q36767551 | Age-related changes in anterior cingulate cortex glutamate in schizophrenia: A (1)H MRS Study at 7 Tesla |
Q36234271 | Anterior cingulate glutamate levels related to clinical status following treatment in first-episode schizophrenia |
Q34193383 | Assessments of function and biochemistry of the anterior cingulate cortex in schizophrenia. |
Q34351880 | Distinct neurometabolic profiles are evident in the anterior cingulate of young people with major psychiatric disorders |
Q37480047 | Executive function, neural circuitry, and genetic mechanisms in schizophrenia |
Q33957510 | Glutamate in schizophrenia: a focused review and meta-analysis of ¹H-MRS studies |
Q44560334 | Glutamate, N-acetyl aspartate and psychotic symptoms in chronic ketamine users |
Q30732395 | Glutamatergic abnormalities in schizophrenia: a review of proton MRS findings |
Q33516442 | Imaging genetics of structural brain connectivity and neural integrity markers |
Q30685335 | Imaging glutamate in schizophrenia: review of findings and implications for drug discovery |
Q28083121 | In vivo assessment of neurotransmitters and modulators with magnetic resonance spectroscopy: application to schizophrenia |
Q46710305 | Increased NAA and reduced choline levels in the anterior cingulum following chronic methylphenidate. A spectroscopic test-retest study in adult ADHD. |
Q37958837 | MR spectroscopy in schizophrenia |
Q38207021 | Magnetic resonance imaging in studying schizophrenia, negative symptoms, and the glutamate system |
Q34013484 | Multivoxel proton MR spectroscopy used to distinguish anterior cingulate metabolic abnormalities in patients with schizophrenia |
Q33626101 | N-acetyl aspartate concentration in the anterior cingulate cortex in patients with schizophrenia: a study of clinical and neuropsychological correlates and preliminary exploration of cognitive behaviour therapy effects |
Q30565982 | Neurometabolites in schizophrenia and bipolar disorder - a systematic review and meta-analysis |
Q46470298 | Proton MRS in twin pairs discordant for schizophrenia |
Q37141400 | Proton magnetic resonance spectroscopy of the substantia nigra in schizophrenia |
Q34048560 | Reduced frontal glutamate + glutamine and N-acetylaspartate levels in patients with chronic schizophrenia but not in those at clinical high risk for psychosis or with first-episode schizophrenia |
Q36323522 | Regional decoupling of N-acetyl-aspartate and glutamate in schizophrenia |
Q30712278 | Relationship between Glutamate Dysfunction and Symptoms and Cognitive Function in Psychosis |
Q37130617 | Spatial distribution and density of oligodendrocytes in the cingulum bundle are unaltered in schizophrenia |
Q30648464 | T2 relaxation effects on apparent N-acetylaspartate concentration in proton magnetic resonance studies of schizophrenia |
Q38232366 | The neurobiology and treatment of first-episode schizophrenia |
Q36817154 | Treatment-Resistant Schizophrenia Patients Show Elevated Anterior Cingulate Cortex Glutamate Compared to Treatment-Responsive |
Search more.